The global Veterinary Zinc Bacitracin market is valued at USD 100.38 million in 2018 and is expected to reach USD 144.76 million by the end of 2025, growing at a CAGR of 5.37% between 2018 and 2025.

This report focuses on Veterinary Zinc Bacitracin volume and value at the global level, regional level and company level. From a global perspective, this report represents overall Veterinary Zinc Bacitracin market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, China and South America.

At the company level, this report focuses on the production capacity, ex-factory price, revenue and market share for each manufacturer covered in this report.

The following manufacturers are covered:
Zoetis
Ceva Corporate
Huvepharma
Lifecome Biochemistry
Qilu Pharmaceutical
Orion Animal Nutrition
Vega Pharma
Tianjin Xinxing Veterinary Pharmaceutical

Segment by Regions
North America
Europe
China
South America
Rest of World

Segment by Type
10% Zinc Bacitracin
15% Zinc Bacitracin
Segment by Application
Pigs
Cattle
Chicken
Others